androgen annihilation in high-risk biochemically relapsed prostate cancer | learn clinical trials
Published 4 years ago • 1.7K plays • Length 4:42Download video MP4
Download video MP3
Similar videos
-
3:50
darolutamide (nubeqa) lupron for high risk prostate cancer | learn about clinical trials
-
6:16
all about clinical trials for advanced prostate cancer (royal) | prostate cancer staging guide
-
11:57
#prostatecancer clinical trials: the benefits and risks | #markscholzmd #pcri
-
4:05
presto study
-
5:11
hormone therapy for high-risk prostate cancer | prostate cancer staging guide
-
28:31
prostate cancer highlights from esmo 2022
-
14:53
finding & choosing clinical trials for #prostatecancer | #markscholzmd #alexscholz #pcri
-
1:05
dr. shore on challenges with adt in recurrent prostate cancer
-
5:54
high-risk prostate cancer: benefit to adding 2nd generation hormone therapy or chemo? | pcri
-
1:40
prostate cancer clinical trial nrg-gu010 (part 1/3)
-
1:22:50
demystifying prostate cancer clinical trials
-
7:04
unorthodox treatments for recurrent prostate cancer (indigo stage) | prostate cancer staging guide
-
2:50
treatment recommendations for high-risk biochemical recurrent prostate cancer
-
8:28
metastatic prostate cancer: androgen receptor biology
-
2:06
dr. chi on androgen deprivation therapy for high-risk metastatic hormone-naive prostate cancer
-
8:10
an introduction to clinical trials - 2021 prostate cancer patient conference
-
3:22
therapy approach in high-risk prostate cancer
-
42:05
androgens, hormonal therapy & response in prostate cancer - summit 2021
-
1:01:01
prostate cancer | inside the issue: exploring the current and future management of high-risk, hor...